Dan Janney
Managing Director
Dan joined Alta immediately following the firm’s founding in 1996, and was a co-founder of the Alta BioPharma effort.
Dan focuses on investments in biopharmaceutical products and therapeutics. He has been directly involved in the funding and development of over 25 life sciences companies. Dan is currently on the board of directors of a number of companies, including Alba Therapeutics, Arête Therapeutics, ChemGenex Pharmaceuticals, Lithera, Phenomix Corporation and ViroBay. In addition, he led Alta’s investments in CoTherix, Dynavax, Endonetics, Ilex Oncology, Definity Health, InterMune and LJL Biosystems.
Prior to joining Alta, he was a senior investment banker at Montgomery Securities, focusing on life sciences companies. Dan is also a member of the advisory board for the Rebecca and John Moores Cancer Center at University of California, San Diego.
He holds a Bachelor of Arts in History from Georgetown University and a Master of Business Administration from the Anderson School at the University of California, Los Angeles.
